Swedish Orphan Biovitrum AB (publ) (SOBI.ST) Financials

SOBI.ST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 81.3 billion 40.9 billion
Dec. 31, 2025 67.4 billion 29.7 billion
Sept. 30, 2025 67.0 billion 31.0 billion
June 30, 2025 68.8 billion 29.7 billion

SOBI.ST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 872.0 million 72.0 million
Dec. 31, 2025 3.0 billion 67.0 million
Sept. 30, 2025 1.8 billion ?
June 30, 2025 1.0 billion 57.0 million

SOBI.ST Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 1.7 billion
Dec. 31, 2025 1.9 billion
Sept. 30, 2025 -2.9 billion
June 30, 2025 794.0 million

SOBI.ST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 940.0 million 7.7 billion 381.0 million
Dec. 31, 2025 1.0 billion 5.4 billion 259.0 million
Sept. 30, 2025 1.0 billion 8.8 billion 265.0 million
June 30, 2025 1.1 billion 8.5 billion 369.0 million

SOBI.ST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 349.4 million
Dec. 31, 2025 348.7 million
Sept. 30, 2025 344.6 million
June 30, 2025 347.2 million

SOBI.ST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 254.0 million 948.0 million 1.9 billion -
Dec. 31, 2025 5.0 million 879.0 million 3.0 billion -
Sept. 30, 2025 8.0 million 754.0 million -4.9 billion -
June 30, 2025 421.0 million 851.0 million 2.0 billion -

SOBI.ST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 7.2 billion 1.7 billion
Dec. 31, 2025 7.8 billion 4.0 billion
Sept. 30, 2025 7.8 billion 9.0 billion
June 30, 2025 6.2 billion 1.4 billion

SOBI.ST

Price: SEK446.60

52 week price:
241.80
447.20

Earnings Per Share: 2.61 SEK

P/E Ratio: 165.44

Exchange: STO

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 149.9 billion

Links: